Pharma Mirror Magazine

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy

Mobile Logo

Browse Tag

National OncoVenture

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA
Pharmaceutical News/Pharmacy

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

February 11, 2021February 11, 2021

Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin

More

Subscribe

Subscribe our Articles, please enter your email below:

Please verify the email sent to your inbox to complete the subscription process. It's safe and free too.

Recent Posts

  • Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval March 1, 2021
  • Accelerating Investigator Recruitment with NLP March 1, 2021
  • New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe February 26, 2021
  • Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site February 24, 2021
  • The Wholesome Value of Holistic Wellness Treatments February 19, 2021

Event Partnership

Purify India

© 2010-2020 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy
Go toTop